Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CARL

CARLSMED (CARL) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $14.42 +2.6% on the day +5.5% over 12 months 52-week range $8.83 – $16.99

Share price and insider trades

CARL closeInsider buyInsider sale
810121518NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $3,400 on 2026-09-30 · Jeffrey BertoliniSold $10,749 on 2026-10-05 · Jeffrey BertoliniSold $2,629,493 on 2026-03-02 · Michael Cordonnier
Bought, 12 months$3.0M
Sold, 12 months$2.6M
Insiders buying1
Insiders selling2

CARLSMED insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $3.0M and 2 sold $2.6M of CARL stock on the open market.

CARL insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2025: $3.0M bought (1 trades)$3.0MQ3 2025Q4 2025Q1 2026: $2.6M sold (1 trades)Q1 2026Q2 2026Q3 2026: $3K sold (1 trades)Q3 2026Q4 2026: $11K sold (1 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$11K1
Q3 2026—0$3K1
Q2 2026—0—0
Q1 2026—0$2.6M1
Q4 2025—0—0
Q3 2025$3.0M1—0

Valuation, profit and volume

Pick score 41/100
P/E (trailing)n/aSector median 24.7
Market value$394MHealth Information Services
Profit margin-57.4%Revenue growth +56.7%
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit−$116KOn all tracked purchases -3.9%

Summary

Over the past 12 months, 1 CARLSMED, INC. insider reported open-market purchases totaling $3.0M, while 2 insiders reported sales totaling $2.6M. 2 of 3 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

CARL stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Oct 6SEC Jeffrey BertoliniCOO Sell Plan 74722,489 held (−3%) $14.39 $11K +0.2% —
Oct 1SEC Jeffrey BertoliniCOO Sell Plan 24322,489 held (−1%) $13.99 $3K +3.1% —
Sep 15SEC Casey M Tansey10% Owner Buy 200,000new position $15.00 $3.0M -3.9% —
Mar 4SEC Michael CordonnierCEO, President Sell 197,8551,356,646 held (−13%) $13.29 $2.6M +8.5% —

Insiders at CARLSMED, INC.

InsiderBoughtSoldLast filingScore
Casey M Tansey10% Owner $3.0M — Sep 15, 2026 —
Michael CordonnierCEO, President — $2.6M Mar 4, 2026 —
Jeffrey BertoliniCOO — $14K Oct 6, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

CARL stock: common questions

Are CARLSMED, INC. insiders buying CARL stock?

In the past 12 months, 1 insiders reported open-market purchases of CARL worth $3.0M. The latest was 10% Owner Casey M Tansey bought $3.0M of CARL at $15.00 — first open-market purchase in our records; opens a new position.

Are CARLSMED, INC. insiders selling CARL stock?

2 insiders reported sales worth $2.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CARL's 52-week range?

Over the past year CARL has traded between $8.83 and $16.99. It last closed at $14.42 on Oct 9, 2026.